These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 32524700)

  • 1. Influences on willingness to use vaginal or oral HIV PrEP during pregnancy and breastfeeding in Africa: the multisite MAMMA study.
    van der Straten A; Ryan JH; Reddy K; Etima J; Taulo F; Mutero P; Taylor J; Piper J; Musara P;
    J Int AIDS Soc; 2020 Jun; 23(6):e25536. PubMed ID: 32524700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acceptability of the Dapivirine Vaginal Ring and Daily Oral Pre-exposure Prophylaxis (PrEP) during Pregnancy in Malawi, South Africa, Uganda, and Zimbabwe.
    Young AM; Stoner MCD; Mathebula F; Mohuba R; Baez A; Seyama L; Mutero P; Etima J; Fabiano Z; Fairlie L; Mayo AJ; Balkus JE; Song M; Bunge K; Piper J; Balan IC; van der Straten A; Montgomery ET
    AIDS Behav; 2024 Nov; 28(11):3615-3628. PubMed ID: 39052199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depression Among Pregnant and Breastfeeding Persons Participating in Two Randomized Trials of the Dapivirine Vaginal Ring and Oral Pre-Exposure Prophylaxis (PrEP) in Malawi, South Africa, Uganda, and Zimbabwe.
    Stoner MCD; Mathebula F; Sedze N; Seyama L; Mohuba R; Fabiano Z; Etima J; Young A; Scheckter R; van der Straten A; Piper J; Noguchi L; Montgomery ET; Balán IC
    AIDS Behav; 2024 Jul; 28(7):2264-2275. PubMed ID: 38526641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. After their wives have delivered, a lot of men like going out: Perceptions of HIV transmission risk and support for HIV prevention methods during breastfeeding in sub-Saharan Africa.
    Flax VL; Hawley I; Ryan J; Chitukuta M; Mathebula F; Nakalega R; Seyama L; Taulo F; van der Straten A;
    Matern Child Nutr; 2021 Apr; 17(2):e13120. PubMed ID: 33325126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adolescent Girls and Young Women's Experiences with Disclosing Oral PrEP or Dapivirine Vaginal Ring Use: a Multi-Country Qualitative Analysis.
    Young AM; Mancuso N; Atujuna M; Tenza S; Chitukuta M; Kemigisha D; Ngure K; van der Straten A; Garcia M; Szydlo D; Soto-Torres L; Roberts ST
    AIDS Behav; 2023 Dec; 27(12):3941-3951. PubMed ID: 37392268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "It's already in your body and it's preventing": a qualitative study of African female adolescent's acceptability and preferences for proxy HIV prevention methods in Cape Town, South Africa.
    Fynn L; Gill K; Wallace M; Atujuna M; Duyver M; Ngcobo P; Spiegel H; Rinehart A; Hosek S; Bekker LG
    BMC Public Health; 2023 Nov; 23(1):2143. PubMed ID: 37919697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protocol for a longitudinal study to evaluate the use of tenofovir-based PrEP for safer conception and pregnancy among women in South Africa.
    Matthews LT; Jaggernath M; Kriel Y; Smith PM; O'Neil K; Haberer JE; Hendrix C; Baeten JM; Ware NC; Wirth K; Psaros C; Bangsberg DR; Smit JA
    BMJ Open; 2019 Jul; 9(7):e027227. PubMed ID: 31350241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding the role of men in women's use of the vaginal ring and oral PrEP during pregnancy and breastfeeding: multi-stakeholder perspectives.
    Musara P; Hartmann M; Ryan JH; Reddy K; Ggita J; Mutero P; Macagna N; Taulo F; Mgodi NM; Piper J; van der Straten A
    Afr J AIDS Res; 2022 Dec; 21(4):354-363. PubMed ID: 36538544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acceptability and Use of the Dapivirine Vaginal Ring and Daily Oral Pre-exposure Prophylaxis (PrEP) During Breastfeeding in South Africa, Malawi, Zimbabwe, and Uganda.
    Stoner MCD; Hawley I; Mathebula F; Horne E; Etima J; Kemigisha D; Mutero P; Dandadzi A; Seyama L; Fabiano Z; Scheckter R; Noguchi L; Owor M; Balkus JE; Montgomery ET
    AIDS Behav; 2023 Dec; 27(12):4114-4123. PubMed ID: 37432541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging evidence from a systematic review of safety of pre-exposure prophylaxis for pregnant and postpartum women: where are we now and where are we heading?
    Joseph Davey DL; Pintye J; Baeten JM; Aldrovandi G; Baggaley R; Bekker LG; Celum C; Chi BH; Coates TJ; Haberer JE; Heffron R; Kinuthia J; Matthews LT; McIntyre J; Moodley D; Mofenson LM; Mugo N; Myer L; Mujugira A; Shoptaw S; Stranix-Chibanda L; John-Stewart G;
    J Int AIDS Soc; 2020 Jan; 23(1):e25426. PubMed ID: 31912985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating the potential impact and cost-effectiveness of dapivirine vaginal ring pre-exposure prophylaxis for HIV prevention.
    Reidy M; Gardiner E; Pretorius C; Glaubius R; Torjesen K; Kripke K
    PLoS One; 2019; 14(6):e0218710. PubMed ID: 31242240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Killing two birds with one stone" - a qualitative study on women's perspectives on the dual prevention pill in Johannesburg, South Africa.
    Tenza S; Mampuru L; Moji M; Zulu S; Begg L; Bruce IV; Reddy K; Friedland BA; Palanee-Phillips T; Mathur S
    BMC Womens Health; 2024 Aug; 24(1):462. PubMed ID: 39174929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perspectives on use of oral and vaginal antiretrovirals for HIV prevention: the VOICE-C qualitative study in Johannesburg, South Africa.
    van der Straten A; Stadler J; Luecke E; Laborde N; Hartmann M; Montgomery ET;
    J Int AIDS Soc; 2014; 17(3 Suppl 2):19146. PubMed ID: 25224610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychosocial determinants of pre-exposure prophylaxis use among pregnant adolescent girls and young women in Cape Town, South Africa: A qualitative study.
    Haribhai S; Khadka N; Mvududu R; Mashele N; Bekker LG; Gorbach P; Coates TJ; Myer L; Joseph Davey DL
    Int J STD AIDS; 2023 Jul; 34(8):548-556. PubMed ID: 36947792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dapivirine vaginal ring for HIV prevention: modelling health outcomes, drug resistance and cost-effectiveness.
    Glaubius R; Ding Y; Penrose KJ; Hood G; Engquist E; Mellors JW; Parikh UM; Abbas UL
    J Int AIDS Soc; 2019 May; 22(5):e25282. PubMed ID: 31074936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-Uninfected Kenyan Adolescent and Young Women Share Perspectives on Using Pre-Exposure Prophylaxis During Pregnancy.
    Pintye J; Beima-Sofie KM; Makabong'O PA; Njoroge A; Trinidad SB; Heffron RA; Baeten JM; Celum C; Matemo D; Kinuthia J; Kelley MC; John-Stewart GC
    AIDS Patient Care STDS; 2018 Dec; 32(12):538-544. PubMed ID: 30036072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV prevention is not all about HIV - using a discrete choice experiment among women to model how the uptake and effectiveness of HIV prevention products may also rely on pregnancy and STI protection.
    Vickerman P; Quaife M; Kilbourne-Brook M; Mvundura M; Eakle R; Terris-Prestholt F
    BMC Infect Dis; 2020 Sep; 20(1):704. PubMed ID: 32977745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk perception and sex behaviour in pregnancy and breastfeeding in high HIV prevalence settings: Programmatic implications for PrEP delivery.
    Joseph Davey D; Farley E; Towriss C; Gomba Y; Bekker LG; Gorbach P; Shoptaw S; Coates T; Myer L
    PLoS One; 2018; 13(5):e0197143. PubMed ID: 29758064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perspectives of South African youth in the development of an implant for HIV prevention.
    Krogstad EA; Atujuna M; Montgomery ET; Minnis A; Ndwayana S; Malapane T; Shapley-Quinn MK; Manenzhe K; Bekker LG; van der Straten A
    J Int AIDS Soc; 2018 Aug; 21(8):e25170. PubMed ID: 30152004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Baseline preferences for oral pre-exposure prophylaxis (PrEP) or dapivirine intravaginal ring for HIV prevention among adolescent girls and young women in South Africa, Uganda and Zimbabwe (MTN-034/IPM-045 study).
    Ngure K; Friedland BA; Szydlo DW; Roberts ST; Garcia M; Levy L; Akello CA; Reddy K; Palanee-Phillips T; Macdonald P; Siziba B; Soto-Torres L; Hosek S; Hillier SL; Nair G; Celum C; van der Straten A
    PLoS One; 2023; 18(6):e0287525. PubMed ID: 37352296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.